Study finds women more often dismissed with psychological explanations for autoimmune symptoms
A Cambridge University analysis reports women face higher odds of being told their autoimmune symptoms are psychological and endure longer diagnostic and treatment delays than men.

A study led by researchers at Cambridge University has found a significant gender disparity in how autoimmune conditions are interpreted and managed, with women more frequently told their symptoms have a psychological origin and experiencing longer waits for clinical assessment and care.
The research, which analysed patient experiences of autoimmune illness, concluded that women were up to 74% more likely than men to be informed that their problems were psychological or related to psychosomatic causes. The authors also report that women waited substantially longer to receive a diagnosis and begin treatment.
Autoimmune diseases—conditions in which the immune system attacks the body’s own tissues—affect an estimated one in ten people worldwide. They can cause a wide range of problems, including persistent tiredness, muscle aches and skin changes such as rashes, the study notes.
Patterns of dismissal and delay
According to the Cambridge team’s analysis, patients who identify as female more often encounter explanations that attribute physical symptoms to emotional or mental factors. Those experiences coincided with extended timelines before specialists confirmed diagnosis or initiated therapy.
The study highlights both the frequency of these encounters and the practical consequences: diagnostic delay can postpone access to appropriate medicines, symptom management and support services. The researchers emphasise that such delays affect health outcomes and patient quality of life.
Why the findings matter
The authors frame their results as evidence of a systemic issue in clinical assessment and decision-making. Given the global prevalence of autoimmune disease, a pattern that systematically disadvantages women has implications for healthcare equity and resource planning.
The study does not propose single causes for the disparity; rather, it documents the scale of the difference in patient-reported experiences and clinical timelines. The researchers suggest that awareness among clinicians of potential biases and clearer diagnostic pathways could reduce avoidable delays.
Although the analysis focuses on reported experiences and statistical associations, it underscores a broader conversation about gendered differences in medical care. The paper adds to other research showing that women can receive different diagnostic and treatment trajectories compared with men across multiple conditions.
The Cambridge University team calls for further work to explore drivers of the disparities and to test interventions aimed at standardising assessment and accelerating diagnosis for all patients with suspected autoimmune disease.
The study’s findings are likely to prompt discussion among clinicians, patient groups and health services about how to ensure timely, evidence-based evaluation for people presenting with symptoms consistent with autoimmune disorders.
Sources
This story was written from reports by these outlets. Read the originals:
- 1.Guardian Science: Women ‘more likely to be told autoimmune conditions are psychological’
- 2.Guardian World: Women ‘more likely to be told autoimmune conditions are psychological’
- 3.Guardian UK: Women ‘more likely to be told autoimmune conditions are psychological’



